Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Testosterone induces leucocyte migration by NADPH oxidase-driven ROS- and COX2-dependent mechanisms

Texto completo
Autor(es):
Chignalia, Andreia Z. [1, 2] ; Oliveira, Maria Aparecida [1] ; Debbas, Victor [3] ; Dull, Randal O. [4] ; Laurindo, Francisco R. M. [3] ; Touyz, Rhian M. [5] ; Carvalho, Maria Helena C. [1] ; Fortes, Zuleica B. [1] ; Tostes, Rita C. [2]
Número total de Autores: 9
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Inst Biomed Sci, BR-05508 Sao Paulo, SP - Brazil
[2] Univ Sao Paulo, Ribeirao Preto Med Sch, BR-14049 Ribeirao Preto, SP - Brazil
[3] Univ Sao Paulo, Sch Med, Inst Heart, BR-01246 Sao Paulo, SP - Brazil
[4] Univ Illinois, Coll Med, Chicago, IL 60612 - USA
[5] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow G12 8TA, Lanark - Scotland
Número total de Afiliações: 5
Tipo de documento: Artigo Científico
Fonte: Clinical Science; v. 129, n. 1, p. 39-48, JUL 2015.
Citações Web of Science: 16
Resumo

The mechanisms whereby testosterone increases cardiovascular risk are not clarified. However, oxidative stress and inflammation seem to be determinants. Herein, we sought to determine whether exogenous testosterone, at physiological levels, induces leucocyte migration, a central feature in immune and inflammatory responses and the mediating mechanisms. We hypothesized that testosterone induces leucocyte migration via NADPH oxidase (NADPHox)-driven reactive oxygen species (ROS) and cyclooxygenase (COX)-dependent mechanisms. Sixteen-week-old Wistar rats received an intraperitoneal injection (5 ml) of either testosterone (10(-7) mol/l) or saline. Rats were pre-treated with 5 ml of sodium salicylate (SS, non-selective COX inhibitor, 1.25x10(-3) mol/l, 1 h prior to testosterone or saline), flutamide (androgen receptor antagonist, 10 (5) mol/l), apocynin (NADPHox inhibitor, 3x10(-4) mol/l), N-{[}2-Cyclohexyloxy-4-nitrophenyl] methanesulfonamide (NS398, COX2 inhibitor, 10(-4) mol/l) or saline, 4 h before testosterone or saline administration. Leucocyte migration was assessed 24 h after testosterone administration by intravital microscopy of the mesenteric bed. Serum levels of testosterone were measured by radioimmunoassay. NADPHox activity was assessed in membrane fractions of the mesenteric bed by dihydroethidium (DHE) fluorescence and in isolated vascular smooth muscle cells (VSMC) by HPLC. NADPHox subunits and VCAM (vascular cell adhesion molecule) expression were determined by immunoblotting. Testosterone administration did not change serum levels of endogenous testosterone, but increased venular leucocyte migration to the adventia, NADPHox activity and expression (P<0.05). These effects were blocked by flutamide. SS inhibited testosterone-induced leucocyte migration (P<0.05). Apocynin and NS398 abolished testosterone-induced leucocyte migration and NADPHox activity (P<0.05). Testosterone induces leucocyte migration via NADPHox-and COX2-dependent mechanisms and may contribute to inflammatory processes and oxidative stress in the vasculature potentially increasing cardiovascular risk. (AU)

Processo FAPESP: 04/15968-1 - Testosterona e estresse oxidativo em células de musculatura lisa muscular em cultura e vasos sanguíneos isolados de ratos
Beneficiário:Andréia Zago Chignalia
Linha de fomento: Bolsas no Brasil - Doutorado Direto
Processo FAPESP: 04/13796-9 - Testosterona e modulação da geração de espécies reativas de oxigênio e nitrogênio no sistema cardiovascular
Beneficiário:Maria Helena Catelli de Carvalho
Linha de fomento: Auxílio à Pesquisa - Regular